<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Elisence – Phase 9: Diabetes &amp; Metabolic Health Intelligence</title>

    <!-- Elisa chat widget script -->
    <script defer src="elisa-chat.js"></script>

    <style>
        :root {
            --bg-space: radial-gradient(circle at top, #04101f 0%, #02040a 45%, #000000 100%);
            --text-main: #e8f4fc;
            --text-soft: #cbd5f5;
            --text-muted: #94a3b8;
            --accent: #38bdf8;
            --accent-soft: #7dd3fc;

            /* BLUE theme for Phase 9 */
            --card-bg: rgba(15, 23, 42, 0.96);
            --card-border: rgba(90, 185, 255, 0.85);
            --shadow-strong: 0 0 22px rgba(0, 140, 255, 0.9), 0 0 40px rgba(0, 40, 120, 0.9);
        }

        * {
            box-sizing: border-box;
        }

        body {
            margin: 0;
            min-height: 100vh;
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Arial, Helvetica, sans-serif;
            background: var(--bg-space);
            color: var(--text-main);
        }

        /* Top dot + label (BLUE, not red) */
        .top-dot {
            position: fixed;
            left: 16px;
            top: 16px;
            width: 11px;
            height: 11px;
            border-radius: 999px;
            background: #38bdf8;
            box-shadow: 0 0 16px rgba(56, 189, 248, 0.95);
            z-index: 900;
        }

        .top-dot-label {
            position: fixed;
            left: 36px;
            top: 11px;
            padding: 6px 10px;
            border-radius: 999px;
            border: 1px solid rgba(148, 163, 184, 0.6);
            background: rgba(15, 23, 42, 0.9);
            font-size: 0.7rem;
            letter-spacing: 0.18em;
            text-transform: uppercase;
            color: #e5f2ff;
            z-index: 900;
        }

        /* Side navigation (pills) – BLUE glow */
        .side-nav {
            position: fixed;
            right: 32px;
            top: 50%;
            transform: translateY(-50%);
            display: flex;
            flex-direction: column;
            gap: 12px;
            z-index: 950;
        }

        .nav-btn {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            padding: 0.65rem 1.5rem;
            border-radius: 999px;
            border: 1px solid rgba(148, 163, 184, 0.75);
            background: radial-gradient(circle at top left,
                rgba(56, 189, 248, 0.32),
                rgba(15, 23, 42, 0.96));
            color: #e2e8f0;
            font-size: 0.78rem;
            letter-spacing: 0.16em;
            text-transform: uppercase;
            text-decoration: none;
            box-shadow: 0 0 14px rgba(15, 23, 42, 0.9);
            backdrop-filter: blur(12px);
            transition: transform 0.16s ease,
                        box-shadow 0.16s ease,
                        border-color 0.16s ease,
                        background 0.16s ease;
        }

        .nav-btn:hover {
            transform: translateX(-2px);
            border-color: rgba(56, 189, 248, 0.95);
            box-shadow: 0 0 22px rgba(56, 189, 248, 0.9);
            background: radial-gradient(circle at top left,
                rgba(56, 189, 248, 0.45),
                rgba(15, 23, 42, 0.98));
        }

        .nav-btn:active {
            transform: translateX(-1px) translateY(1px) scale(0.99);
        }

        /* Layout wrapper */
        .page-wrapper {
            max-width: 1200px;
            margin: 0 auto;
            padding: 96px 1.8rem 72px 1.8rem;
        }

        .hero-area {
            margin-bottom: 2.4rem;
        }

        .phase-hero-card {
            background: radial-gradient(circle at top left,
                rgba(56, 189, 248, 0.35),
                rgba(15, 23, 42, 0.98));
            border-radius: 26px;
            border: 1px solid var(--card-border);
            box-shadow: var(--shadow-strong);
            padding: 1.6rem 1.8rem;
        }

        .phase-hero-inner {
            display: flex;
            gap: 1.8rem;
            align-items: stretch;
        }

        .phase-hero-logo-box {
            flex: 0 0 290px;
            border-radius: 22px;
            background: radial-gradient(circle at top, #0b1220, #020617);
            display: flex;
            align-items: center;
            justify-content: center;
            padding: 0.75rem;
            box-shadow: 0 0 24px rgba(15, 23, 42, 0.9),
                        0 0 40px rgba(15, 23, 42, 0.9);
        }

        .phase-hero-logo {
            width: 100%;
            max-width: 360px;
            height: auto;
            border-radius: 18px;
            box-shadow: 0 0 28px rgba(15, 23, 42, 0.95);
        }

        .phase-hero-text-box {
            flex: 1;
            display: flex;
            flex-direction: column;
            justify-content: center;
        }

        .phase-label {
            font-size: 0.78rem;
            text-transform: uppercase;
            letter-spacing: 0.18em;
            color: var(--text-muted);
            margin-bottom: 0.3rem;
        }

        .phase-title {
            font-size: 1.9rem;
            letter-spacing: 0.06em;
            text-transform: uppercase;
            color: #f9fafb;
            margin: 0 0 0.35rem 0;
        }

        .phase-subtitle {
            font-size: 0.95rem;
            letter-spacing: 0.14em;
            text-transform: uppercase;
            color: var(--accent-soft);
            margin-bottom: 0.6rem;
        }

        .phase-lead {
            font-size: 0.98rem;
            color: var(--text-soft);
            margin-bottom: 0.7rem;
        }

        .phase-hero-bullets {
            margin: 0.3rem 0 0 0;
            padding-left: 1.1rem;
            font-size: 0.9rem;
            color: #e0f2fe;
        }

        .phase-hero-bullets li {
            margin-bottom: 0.2rem;
        }

        /* Phase detail cards */
        .phase-main {
            max-width: 1100px;
            margin: 0 auto;
        }

        .info-card {
            background: var(--card-bg);
            border-radius: 18px;
            border: 1px solid var(--card-border);
            box-shadow: var(--shadow-strong);
            padding: 1.8rem 1.7rem;
            margin-bottom: 1.8rem;
        }

        .info-card h2 {
            margin-top: 0;
            margin-bottom: 0.85rem;
            font-size: 1.3rem;
            color: var(--accent-soft);
        }

        .info-card h3 {
            margin-top: 1.1rem;
            margin-bottom: 0.4rem;
            font-size: 1.02rem;
            color: #bae6fd;
        }

        .info-card p {
            margin: 0.35rem 0;
            font-size: 0.94rem;
            color: #e5f2ff;
        }

        .info-card ul {
            margin: 0.45rem 0 0.25rem 1.2rem;
            padding-left: 0.3rem;
        }

        .info-card li {
            margin-bottom: 0.32rem;
            font-size: 0.93rem;
        }

        .subtle {
            font-size: 0.88rem;
            color: var(--text-muted);
        }

        /* Responsive */
        @media (max-width: 900px) {
            .page-wrapper {
                padding: 80px 1.2rem 80px 1.2rem;
            }

            .phase-hero-inner {
                flex-direction: column;
            }

            .phase-hero-logo-box {
                flex: 0 0 auto;
            }

            .side-nav {
                right: 50%;
                bottom: 18px;
                top: auto;
                transform: translateX(50%);
                flex-direction: row;
                flex-wrap: wrap;
                justify-content: center;
                gap: 10px;
            }

            .nav-btn {
                font-size: 0.7rem;
                padding: 0.6rem 1.1rem;
            }

            .info-card {
                padding: 1.5rem 1.35rem;
            }
        }
    </style>
</head>
<body>

<div class="top-dot"></div>
<div class="top-dot-label">ELISENCE</div>

<nav class="side-nav">
    <a class="nav-btn" href="index.html">Home</a>
    <a class="nav-btn" href="index.html#phases">Phases</a>
    <a class="nav-btn" href="about.html">About</a>
    <a class="nav-btn" href="story.html">Story</a>
    <a class="nav-btn" href="video.html">Videos</a>
    <a class="nav-btn" href="contact.html">Contact</a>
</nav>

<div class="page-wrapper">
    <!-- HERO -->
    <section class="hero-area">
        <div class="phase-hero-card">
            <div class="phase-hero-inner">
                <div class="phase-hero-logo-box">
                    <img src="elisence.png"
                         alt="Elisence – Global Digital Health & Humanity Platform"
                         class="phase-hero-logo">
                </div>
                <div class="phase-hero-text-box">
                    <div class="phase-label">PHASE 9</div>
                    <h1 class="phase-title">Diabetes &amp; Metabolic Health Intelligence</h1>
                    <div class="phase-subtitle">
                        GLUCOSE · WEIGHT · MEDICATION · LIFESTYLE · SAFE &amp; NON-DIAGNOSTIC
                    </div>
                    <p class="phase-lead">
                        Phase 9 is the Diabetes &amp; Metabolic Health brain of Elisence. It connects glucose,
                        weight, medications and everyday life into <strong>clear, non-diagnostic, audit-ready
                        patterns</strong> so that people, families and clinicians can understand what is really
                        happening over time – without ever replacing a doctor.
                    </p>
                    <ul class="phase-hero-bullets">
                        <li>Brings glucose, weight, GLP-1 and lifestyle into one safe, unified story.</li>
                        <li>Speaks in calm, practical language aligned with NHS / NICE style thinking.</li>
                        <li>Built for citizens, clinicians and ministries who need trusted metabolic intelligence.</li>
                    </ul>
                </div>
            </div>
        </div>
    </section>

    <!-- DETAIL CARDS -->
    <main class="phase-main">

        <!-- 1. WHAT PHASE 9 IS -->
        <section class="info-card">
            <h2>1. What Phase 9 Really Is</h2>
            <p>
                Phase 9 is not just a “sugar tracker”. It is a structured
                <strong>Diabetes &amp; Metabolic Health Intelligence layer</strong> that understands patterns across:
                glucose, weight, medications, sleep, food, movement and stress.
            </p>
            <p>
                The purpose is simple: give people living with or at risk of diabetes a trusted companion that helps
                them see how daily choices and treatments behave over weeks and months – while clearly reminding them
                that medical decisions stay with qualified clinicians.
            </p>
            <p>
                Phase 9 works for:
            </p>
            <ul>
                <li>People with Type 2 diabetes who want clarity, not fear.</li>
                <li>Those with pre-diabetes who need to see trends early.</li>
                <li>Users on GLP-1 and other metabolic drugs who want to see real-world effect safely.</li>
                <li>Families caring for parents or children with metabolic conditions.</li>
                <li>Clinics and ministries that need anonymised, population-level metabolic insights.</li>
            </ul>
        </section>

        <!-- 2. DATA & SIGNALS -->
        <section class="info-card">
            <h2>2. Data &amp; Signals Phase 9 Understands</h2>
            <p>
                Phase 9 brings together multiple signal streams into a single, readable picture.
            </p>

            <h3>2.1 Glucose &amp; Laboratory Signals</h3>
            <ul>
                <li>Capillary glucose readings (finger-prick logs) with time-of-day and context tags.</li>
                <li>Continuous glucose trends summarised into safe, comprehensible daily and weekly patterns.</li>
                <li>Laboratory markers such as HbA1c, lipids and kidney function as part of a long-term view.</li>
            </ul>

            <h3>2.2 Weight, Waist &amp; Body Trends</h3>
            <ul>
                <li>Weight trajectories over weeks and months to reduce focus on single-day fluctuations.</li>
                <li>Optional waist and body-composition inputs for people and clinics who track them.</li>
                <li>Direct connection to Phase 3 (Weight &amp; GLP-1) so users see “scale + sugar” together.</li>
            </ul>

            <h3>2.3 Medication &amp; Everyday Behaviour</h3>
            <ul>
                <li>Structured logging of GLP-1, insulin, oral agents and other metabolic medications.</li>
                <li>Patterns of meals, walking, exercise, sleep and high-stress periods.</li>
                <li>“Before / after” windows that show how habits influence metabolic calm or volatility.</li>
            </ul>

            <p class="subtle">
                All of these are treated as <em>signals</em>, not diagnoses. The intelligence is in how the signals
                are organised and explained.
            </p>
        </section>

        <!-- 3. PATTERN ENGINE & JOURNEYS -->
        <section class="info-card">
            <h2>3. Pattern Engine &amp; Everyday Journeys</h2>
            <p>
                Phase 9 focuses on real-life journeys – how days, weeks and seasons feel – not just isolated numbers.
            </p>

            <h3>3.1 Daily Metabolic Story</h3>
            <ul>
                <li>Shows how mornings, afternoons and evenings typically behave for each person.</li>
                <li>Distinguishes stable days from days with many spikes and drops.</li>
                <li>Helps users recognise their own “good days” patterns without blame or shame.</li>
            </ul>

            <h3>3.2 Medication Context (Including GLP-1)</h3>
            <ul>
                <li>Organises data around injections, tablets and dose changes.</li>
                <li>Highlights safe, non-diagnostic patterns such as “numbers in the weeks after dose adjustment”.</li>
                <li>Supports better conversations between people and their care teams.</li>
            </ul>

            <h3>3.3 Lifestyle &amp; Sleep</h3>
            <ul>
                <li>Connects sleep duration, late meals, heavy days and movement with metabolic patterns.</li>
                <li>Uses neutral, supportive language – no guilt, no moral judgement.</li>
                <li>Encourages realistic actions: small walks, better sleep hygiene, consistent mealtimes.</li>
            </ul>
        </section>

        <!-- 4. SAFETY, ETHICS & NON-DIAGNOSTIC BOUNDARIES -->
        <section class="info-card">
            <h2>4. Safety, Ethics &amp; Non-Diagnostic Boundaries</h2>
            <p>
                Diabetes care can be high-risk if handled carelessly. Phase 9 is designed to stay
                <strong>honest, regulated and careful</strong> about its limits.
            </p>

            <h3>4.1 Non-Diagnostic by Design</h3>
            <ul>
                <li>No statements like “you have diabetes” or “you are cured”.</li>
                <li>Instead: “Your pattern looks like…, here are questions to discuss with your clinician.”</li>
                <li>Risk language is gentle, specific and clearly labelled as information, not a verdict.</li>
            </ul>

            <h3>4.2 Emergency &amp; Red-Flag Behaviour</h3>
            <ul>
                <li>Severe symptoms (e.g. chest pain, difficulty breathing, confusion, suspected hypo/hyper) trigger
                    urgent, safety-first copy.</li>
                <li>Guidance always points towards emergency services, hotlines or clinicians – never self-treatment.</li>
                <li>No self-harm content, no crash-diet challenges, no unsafe competitions.</li>
            </ul>

            <h3>4.3 Privacy &amp; Data Protection</h3>
            <ul>
                <li>No silent sharing of personal metrics with employers or insurers.</li>
                <li>Data used for research or ministry dashboards is anonymised and k-anonymous.</li>
                <li>People decide what to log, what to keep private and what to share with their care teams.</li>
            </ul>
        </section>

        <!-- 5. INTEGRATION WITH OTHER PHASES -->
        <section class="info-card">
            <h2>5. How Phase 9 Connects to the Rest of Elisence</h2>
            <p>
                Phase 9 sits at the centre of the metabolic story and connects deeply with other Elisence cores.
            </p>

            <h3>5.1 With Phase 3 (Weight &amp; GLP-1)</h3>
            <ul>
                <li>Shares understanding of weight, appetite and GLP-1 response over time.</li>
                <li>Lets people and clinicians see weight and glucose trends together, safely.</li>
            </ul>

            <h3>5.2 With Phase 5 (Healthy Dopamine &amp; Behaviour)</h3>
            <ul>
                <li>Healthy Dopamine engine provides small, ethical celebrations for metabolic wins.</li>
                <li>No addictive loops – just calm encouragement for sustainable habits.</li>
            </ul>

            <h3>5.3 With Phase 6 (Global Medication Intelligence)</h3>
            <ul>
                <li>Uses structured medication knowledge: GLP-1, insulin, oral agents and co-morbidities.</li>
                <li>Organises complex regimens so conversations with clinicians become clearer.</li>
            </ul>

            <h3>5.4 With Phase 7 &amp; Phase 8</h3>
            <ul>
                <li>Women+ (Phase 7) can see how metabolic signals interact with cycles and life stages.</li>
                <li>Advanced Health Engine (Phase 8) uses anonymised aggregates for public-health insights, not surveillance.</li>
            </ul>

            <h3>5.5 With Phase 10 &amp; Phase 11</h3>
            <ul>
                <li>Phase 10 lets people share safe achievements and milestones socially, if they choose.</li>
                <li>Phase 11 (Security &amp; Passport) protects every API call and dashboard with Zero-Trust headers.</li>
            </ul>
        </section>

        <!-- 6. INVESTOR & MINISTRY VALUE -->
        <section class="info-card">
            <h2>6. Why Phase 9 Matters for Investors &amp; Ministries</h2>
            <p>
                Diabetes and metabolic disease are among the biggest drivers of cost and suffering in global health.
                Phase 9 is designed for that reality.
            </p>

            <h3>6.1 Real, Measurable Impact Space</h3>
            <ul>
                <li>Huge populations living with or at risk of diabetes in every country.</li>
                <li>Strong links with cardiovascular, kidney and mental-health outcomes.</li>
                <li>Clear cost burden on health systems, insurers and families.</li>
            </ul>

            <h3>6.2 Differentiation vs Simple Tracking Apps</h3>
            <ul>
                <li>Most tools show graphs but ignore safety, governance and multi-phase integration.</li>
                <li>Elisence Phase 9 is governance-first, audit-ready and designed for ministry partnerships.</li>
                <li>Focuses on long-term outcomes and system-level intelligence, not just step counts.</li>
            </ul>

            <h3>6.3 Regulatory-Friendly Design</h3>
            <ul>
                <li>Non-diagnostic posture compatible with EU MDR and FDA CDS frameworks.</li>
                <li>Hazard logs, WORM audit and structured evidence packs for NHS / GCC style reviews.</li>
                <li>Clear path for clinician-only decision-support modules when partners require it.</li>
            </ul>
        </section>

        <!-- 7. LIMITATIONS -->
        <section class="info-card">
            <h2>7. Limitations (Clear &amp; Honest)</h2>
            <p>
                By design, Phase 9 does <strong>not</strong>:
            </p>
            <ul>
                <li>Diagnose diabetes, remission, complications or co-morbidities.</li>
                <li>Start, stop or change any medication or insulin plan.</li>
                <li>Provide medical triage or emergency instructions.</li>
                <li>Replace endocrinologists, diabetologists, dietitians or primary-care teams.</li>
                <li>Offer “miracle” diets or unsafe quick-fix challenges.</li>
            </ul>
            <p>
                These limits protect citizens, clinicians and ministries, and keep Elisence inside a safe, globally
                deployable regulatory perimeter.
            </p>
        </section>

        <!-- 8. ONE-SENTENCE SUMMARY -->
        <section class="info-card">
            <h2>8. One-Sentence Summary</h2>
            <p>
                Phase 9 is the <strong>Diabetes &amp; Metabolic Health Intelligence</strong> layer of Elisence – a
                respectful, non-diagnostic engine that organises glucose, weight, medication and lifestyle signals into
                clear, audit-ready insights for citizens, clinicians and ministries around the world.
            </p>
        </section>

    </main>
</div>

<!-- Elisa chat widget root -->
<div id="elisa-chat-root"></div>

</body>
</html>
